Ranbaxy gathers momentum in novel drug delivery
India's Ranbaxy Laboratories has stepped up its efforts to dominate the domestic novel drug delivery system (NDDS) market, in-licensing two new drugs from Europe in as many weeks.
Archives for May 24, 2006
Matritech releases first urine test to id tumours
Matritech has introduced the first urine test that indicates whether a bladder malignancy is likely to be dangerous, providing early identification of high-risk tumours and therefore increasing the success of subsequent treatment.
Date set for major outsourcing conference
Registration is now open for the annual "Pharmaceutical Outsourcing of Discovery Chemistry, Advanced Intermediates and API's" conference, which this year celebrates its 10th anniversary.
Asian CRO bags new diabetes contract
US biotech company Spherix has selected Singapore-based clinical research organisation (CRO) Gleneagles to take charge of the Phase III clinical trial program for its new Type 2 diabetes drug, Naturlose.
BioProgress and Uluru join films
Bioprogress has signed a development agreement with emerging speciality pharmaceutical company Uluru to combine their film technologies in order to create an edible film which allows sustained release of active ingredients.
Cambrex to biomanufacture for Merrimack
Life sciences firm Cambrex has agreed a contract for the production of clinical trial quantities of Merrimack Pharmaceuticals' recombinant immunomodulatory serum protein, as its experience in the downstream purification of proteins pays off.
Biophan files new nanoprocessing patent
Biophan has filed the first patent to come out of its newly-formed relationship with NaturalNano to develop new and improved ways of controlled-release drug delivery.
Drug companies compelled to come clean over clinical trials
The World Health Organization (WHO) has announced details of a new initiative compelling drug companies to register all clinical trials on humans after public pressure for more transparency.